Vyome (HIND) Stock: Buy, Sell, or Hold?
HIND - Vyome Holdings, Inc. Common Stock
$2.03
-0.01 (-0.49%)
▼
5d:
+5.18%
30d:
-8.14%
90d:
-4.69%
HOLD
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When HIND Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HIND shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: HIND shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: HIND is currently trading at $2.03, which is considered slightly low relative to its 30-day fair value range of $2.00 to $2.20.
Technical Outlook: Technically, HIND is showing sideways momentum. Immediate support is located at $1.89, while resistance sits at $2.20.
Market Sentiment: HIND scores 84/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.83 (+335.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HIND is showing sideways momentum. Immediate support is located at $1.89, while resistance sits at $2.20.
Market Sentiment: HIND scores 84/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.83 (+335.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.00 -
$2.20
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (84/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 335.1% below Wall St target ($8.83)
- CAUTION: Bottoming setup, but lagging the sector by 18% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$2.00 -
$2.20
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.89
Resistance Level
$2.20
Current Trend
Sideways
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.54
Wall Street Target
$8.83
(+335.1%)
Revenue Growth (YoY)
-46.0%
Share & Embed Analysis
Last updated: September 29, 2026 11:01 AM ET
Data refreshes hourly during market hours. Next update: 12:01 PM
Data refreshes hourly during market hours. Next update: 12:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HIND showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 48 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 54 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$21 | 56 HOLD |